华康股份股价跌1.06%，华夏基金旗下1只基金重仓，持有415.33万股浮亏损失66.45万元

Core Viewpoint - Huakang Co., Ltd. experienced a decline of 1.06% on December 30, with a stock price of 14.92 yuan per share and a total market capitalization of 4.522 billion yuan [1] Company Overview - Zhejiang Huakang Pharmaceutical Co., Ltd. was established on July 10, 2001, and went public on February 9, 2021. The company specializes in the research, production, and sales of various functional sugar alcohols and starch sugar products, including xylitol, sorbitol, maltitol, and fructose syrup [1] - The revenue composition of the company is as follows: crystalline sugar alcohol products account for 54.36%, liquid sugars and alcohols for 32.46%, and other products for 13.18% [1] Shareholder Information - Huaxia Fund has a presence among the top ten circulating shareholders of Huakang Co., Ltd. The Huaxia Excellent Growth Mixed A Fund (024928) entered the top ten shareholders in the third quarter, holding 4.1533 million shares, which represents 1.39% of the circulating shares [2] - The estimated floating loss for the fund today is approximately 664,500 yuan [2][5] Fund Performance - The Huaxia Excellent Growth Mixed A Fund (024928) was established on August 12, 2025, with a current scale of 956 million yuan and a cumulative return of 16.17% since inception [3] - The fund manager, Zhong Shuai, has been in position for 5 years and 157 days, managing assets totaling 13.26 billion yuan. The best fund return during his tenure is 184.12%, while the worst return is -0.15% [4]